2026 | LAI Resources: Pocket Guide, Videos, Administrative Toolkit

Sign in (or create a FREE account) to register or access your existing registration.

Summary of the LAI Resources

LAI Pocket Guide: Psychotropic Long-Acting Injectables

Order a print copy!

The pocket guide is a resource that pharmacists and other members of the health care team can easily access in practice to quickly locate key information on each of the available psychotropic LAIs. This information includes indications, formulations, pharmacokinetics, dosing, management of missed doses, how supplied, storage, and clinical pearls on preparation and administration. The pocket guide also contains QR codes and links to videos and additional information on product preparation and administration. Learners desiring a print copy can order directly here: Order a print copy! See the changelog below for what has changed in the latest update(s).

The LAI Pocket Guide is not intended to be a comprehensive source of drug information on these topics. The contents of this book should not be interpreted as official policy of the American Association of Psychiatric Pharmacists (AAPP) or an endorsement of any product(s). Nor should they be considered as a substitute for the professional judgement of practitioners and clinicians.

Last updated: May 2026

This pocket guide is supported by an educational grant from Johnson & Johnson.

LAI Administration Videos

The administration videos help you visualize appropriate LAI injection techniques to perfect your administration and train team members. Administration videos are courtesy of SMI Adviser.

Funding for SMI Adviser was made possible by Grant No. SM080818 from SAMHSA of the U.S. Department of Health and Human Services (HHS). The contents are those of the author(s) and do not necessarily represent the official views of, nor an endorsement by, SAMHSA/HHS or the U.S. Government.

LAI Administrative Toolkit

The administrative toolkit contains helpful resources designed to assist with building and expanding LAI clinics, such as an appointment card, informed consent template, referral form, and communication letter between the pharmacist and prescriber.

The Administrative Toolkit is not intended to be a comprehensive source of information on these topics. The contents fo this toolkit should not be interpreted as official policy of the American Association of Psychiatric Pharmacists (AAPP) or an endorsement of any product(s). Nor should they be considered as a substitute for the professional judgement of practitioners and clinicians.

Although Risvan® and Rykindo® are not commercially available in the United States, they are included in the course materials because they carry FDA‑approved labeling.

Last updated: May 2026

This pocket guide is supported by an educational grant from Johnson & Johnson.

Target Audience

We invite you to participate in this online course if you are a pharmacist, nurse, or other health care professional interested in administering and/or learning more about psychotropic long-acting injectables for patients living with serious mental illness or substance use disorders.

Course Requirements

To receive ACPE credit for this session, you must:

  • Register for this course.
  • Complete the pre-test (if applicable) before starting the activity.
  • Review the full content of the activity and reflect upon its teachings.
  • Complete the post-test at the end of the activity no later than the closing activity date.
  • Complete the evaluation at the end of the activity.
  • If necessary, complete the post-test retest no later than the closing activity date.
  • Receive a passing grade (TBD).
  • Provide the necessary details in your profile to ensure correct reporting by AAPP to CPE Monitor.

Continuing Education Credit and Disclosures

Faculty: Megan Ehret, PharmD, MS, BCPP, FAAPP discloses: Speaker's Bureau - Saladax Biomedical, LLC

Planning Committee/Peer Reviewers:

  • Andria F. Church, PharmD, BCPP has nothing to disclose
  • Beth DeJongh, PharmD, FAAPP, BCPP, BCPS has nothing to disclose

*All identified conflicts of interest have been mitigated.


AAPP Disclaimer: Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications on dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

Unlabeled Use Disclosure: Faculty of this CE activity may include discussions of products or devices that are not currently labeled for use by the FDA. The faculty have been informed of their responsibility to disclose to the audience if they will be discussing off-label or investigational uses (any uses not approved by the FDA) of products or devices. The faculty, planners, and American Association of Psychiatric Pharmacists do not endorse the use of any product outside of the FDA labeled indications. Medical professionals should not utilize the procedures, products, or diagnosis techniques discussed during this activity without evaluation of their patient for contraindications or dangers of use. 

AAPP owns the copyright, is licensed or has received permissions for use of, or is otherwise permitted to use copyrighted materials within any CPE activity. Authors and speakers are required to obtain necessary copyright permissions for content in CPE activities. AAPP complies with copyright laws and regulations.

View AAPP's Privacy Policy. AAPP's Terms of Use and other policies on education programs, resources, toolkits, and other web based content/offerings are available here.

Questions? Contact AAPP.

It is the policy of AAPP to ensure independence, balance, objectivity, scientific rigor, and integrity in continuing education activities. Those involved in the development of this continuing education activity have made all reasonable efforts to ensure that information contained herein is accurate in accordance with the latest available scientific knowledge at the time of accreditation of this continuing education activity. Information regarding drugs (e.g., their administration, dosages, contraindications, adverse reactions, interactions, special warnings, and precautions) and drug delivery systems is subject to change, however, and the reader is advised to check the manufacturer’s package insert for information concerning recommended dosage and potential problems or cautions prior to dispensing or administering the drug or using the drug delivery systems.

Fair balance is achieved through ongoing and thorough review of all materials produced by faculty, and all educational and advertising materials produced by supporting organizations, prior to educational offerings. Approval of credit for this continuing education activity does not imply endorsement by AAPP for any product or manufacturer identified.

This activity is supported by an educational grant from Johnson & Johnson.